Funding This work was funded by the Medical Research Council (MRC) Network of Hubs for Trials Methodology Research (HTMR) (MR/L004933/1-R34) and undertaken with the support of the MRC ConDuCT Hub (Collaboration and innovation in Difficult or complex randomised Controlled Trials – G0800800). Availability of data and materials The datasets generated and analysed during the current study are not publicly available due to the nature of the consent provided by participants, but anonymised data are available from the corresponding author on reasonable request.Peer reviewedPublisher PD
OBJECTIVE: To characterise and analyse the experiences of trial researchers of if and how conflicts ...
PURPOSE: We examine the levels of post-trial responsibility ascribed to different stakeholders, foll...
Objective: To describe patient perspectives on recruitment and retention in clinical trials. Study D...
Background: The oversight and conduct of a randomised controlled trial involves several stakeholders...
Abstract Background The oversight and conduct of a randomised controlled trial involves several stak...
BACKGROUND: Clinical trials oversight by a Trial Steering Committee (TSC) is mandated by Good Clinic...
BACKGROUND: Trial oversight is important for trial governance and conduct. Patients and/or lay membe...
Funding RECAP was funded by the Academy of Medical Sciences (SBF002\1014) and KG was funded by a Med...
Acknowledgements We are thankful to Marie Miller, Imperial Clinical trials Units’ patient and public...
Patient and public involvement (PPI) is advocated in clinical trials yet evidence on how to optimise...
BACKGROUND: In comparison with other study designs, randomised trials are regarded as particularly l...
Background: Stakeholder involvement includes not just patients and public, but also those delivering...
Acknowledgements The authors would like to thank all interviewees that took part in this study, as w...
Acknowledgements The authors would like to thank Rumana Newlands (RN) for her work in conducting the...
Acknowledgements This work was supported by the Medical Research Council (MRC) Network of Hubs for T...
OBJECTIVE: To characterise and analyse the experiences of trial researchers of if and how conflicts ...
PURPOSE: We examine the levels of post-trial responsibility ascribed to different stakeholders, foll...
Objective: To describe patient perspectives on recruitment and retention in clinical trials. Study D...
Background: The oversight and conduct of a randomised controlled trial involves several stakeholders...
Abstract Background The oversight and conduct of a randomised controlled trial involves several stak...
BACKGROUND: Clinical trials oversight by a Trial Steering Committee (TSC) is mandated by Good Clinic...
BACKGROUND: Trial oversight is important for trial governance and conduct. Patients and/or lay membe...
Funding RECAP was funded by the Academy of Medical Sciences (SBF002\1014) and KG was funded by a Med...
Acknowledgements We are thankful to Marie Miller, Imperial Clinical trials Units’ patient and public...
Patient and public involvement (PPI) is advocated in clinical trials yet evidence on how to optimise...
BACKGROUND: In comparison with other study designs, randomised trials are regarded as particularly l...
Background: Stakeholder involvement includes not just patients and public, but also those delivering...
Acknowledgements The authors would like to thank all interviewees that took part in this study, as w...
Acknowledgements The authors would like to thank Rumana Newlands (RN) for her work in conducting the...
Acknowledgements This work was supported by the Medical Research Council (MRC) Network of Hubs for T...
OBJECTIVE: To characterise and analyse the experiences of trial researchers of if and how conflicts ...
PURPOSE: We examine the levels of post-trial responsibility ascribed to different stakeholders, foll...
Objective: To describe patient perspectives on recruitment and retention in clinical trials. Study D...